John Igoe, a Florida-based partner in Edwards Wildman
's Business Department, and Tamer Tullgren, an associate in the firm's Chicago office, represented the venture capital firms in Miami-based TissueTech's completion of a $10 million round of growth equity financing from Ballast Point Ventures and River Cities Capital Funds, reported the Miami Herald. The article, "Miami-based TissueTech Receives $10 Million in Funding
," noted that TissueTech is a leader in regenerative amniotic tissue-based products for use in the ophthalmology, optometry, musculoskeletal and wound care markets and that the funding will be largely used to accelerate commercial efforts and further research and development. Ballast Point Ventures is a later stage venture capital fund based in St. Petersburg, Fla., and River Cities Capital Funds is headquartered in Cincinnati, Ohio.